On a Monday last month in -Myeongdong, a popular downtown shopping haven in Seoul, the pedestrian walkways were slippery from the previous day’s snowfall. Despite the chilly minus-7?C, the district was abuzz with life as shoppers flocked to the stores looking for good bargains.
The most prominent sight was the cosmetics and beauty stores that beckoned shoppers in nearly every street.
Brands including the Etude House, the Face Shop, Tony Moly, Missha, Nature Republic, Skin Food and Laneige were all vying for shoppers’ attention. Conversing in fluent Mandarin and Japanese, promoters were busy dishing out free samples to usher in customers at the store fronts.
Among these prominent brands was a rising force, AmorePacific Corp — the largest cosmetic enterprise in South Korea that owns more than 20 brands of cosmetics, personal care and healthcare products.
Its cosmetics include skin care, make-up and fragrances. Its personal care products consist of shampoos and toothpastes; while green tea and mineral water are examples of its other goods.
AmorePacific’s well-known cosmetic brands are Hera, Mamonde, Sulhwasoo, Laneige and Iope, to name a few.
The company’s stocks closed at 1,077,000 won (US$970) on Jan 28, beating tech giant Samsung Electronics Co’s 1,010,000 won. Since that day, AmorePacific’s 52-week high was 1,223,000 won, while that of Samsung was 1,014,000 won.
At the end of last year, AmorePacific enjoyed a dominant position in South Korean’s beauty care market with a 39 percent share, ahead of its local rival LG Household & Health Care Ltd’s 17 percent (whose brands include the Face Shop), AmorePacific international strategy team's manager Park Nam-ki said in an interview at the firm’s Seoul headquarters late last month.
However, the company — which prides itself on its corporate philosophy of being an “Asian Beauty Creator” — isn’t content just with success on its home turf.
It has a rather ambitious vision: By 2015, it aims to be among the world’s top 10 cosmetic brands in terms of revenues. Overseas sales would make up about 30 percent of total sales by then, up from 12 percent last year.
AmorePacific ranked No. 20 in 2009 in the global beauty care industry. It had US$1.8 billion in revenues in 2009, up 20.7 percent from 2008.
Top firm L’Oreal Group of France reported flat sales of US$24.4 billion in 2009, while No. 2 Procter & Gamble Co of the US saw sales dip 6 percent to US$18.6 billion. The British-Dutch brand Unilever took the No. 3 spot with US$15.4 billion in sales, up 4.1 percent from 2008.
The only two Asian brands in the top 10 were Shiseido Co at No. 6 and Kao Corp at No. 8 — both from Japan.
“AmorePacific has the know-how to achieve success. We are the most established cosmetic firm in South Korea and we own the biggest pool of R&D [research and development] staff,” the firm’s public relations specialist Lee Yoon-ah said.
The company has more than 350 researchers studying red ginseng, green tea, bamboo sap and other botanical ingredients in Asia for use in its entire portfolio of products, she said.
AmorePacific, which was founded in 1945, opened the first lab in the history of South Korean cosmetic industry in August 1954.
It unveiled its first R&D center in October 1978, and its second facility, called “Mizium,” became operational in September last year.
Mizium is located in Yongin, about one-and-a-half hours drive from Seoul. It houses spacious labs and public spaces that encourage interaction among staff. It also has a 320-seat cafeteria and an exercise space.
AmorePacific is pouring 3.5 percent of total sales into R&D each year in a bid to make sure its products keep abreast with the changing consumer needs and the latest technology, according to Lee.
And the key to increasing its overseas sales to 30 percent of it overall sales — an equivalent of 1.2 trillion won — by 2015 lies in China, Park added.
AmorePacific’s overseas revenues were 337 billion won last year, up from 283 billion won a year ago. China alone took up the bulk, or 58 percent, of total overseas sales last year, compared with 31 percent from France and 4 percent from the US, the company’s statistics showed.
The company forecast that China — which contributed more than 160 billion won to last year’s sales — would see sales advance to 204 billion won this year and 850 billion won by 2015.
To ensure it is on the right track, AmorePacific is set to unveil its third brand — Sulhwasoo — in China next month. The luxury brand will have seven counters at major department stores in Beijing and Shanghai by the end of this year, Lee said.
AmorePacific currently carries two brands in China: the premium Laneige and the down-market Mamonde.
“We didn’t have a complete cosmetic portfolio in China. These additional brands will help us strengthen the brand,” Park said, adding that if these brands gain ground, AmorePacific would rank among China’s top 5 skincare brands by 2015.
In Taiwan, AmorePacific made its entry in 1989 by selling Laneige and Iope brands through a joint venture. Iope is a cosmeceutical brand that targets those in their mid-20s to mid-30s.
As a result of the great success of Laneige, AmorePacific established a separate, wholly-owned subsidiary for the brand in Taiwan in 2004.
Laneige currently operates 18 counters in Taiwan’s major department stores, including Pacific Sogo Department Stores Co (太平洋崇光百貨) and Far Eastern Department Stores (遠東百貨), according to Park.
“Pending successful results of both the Laneige and Iope brands in 2011, AmorePacific is planning to enhance store and brand marketing operations in Taiwan,” he added.
While determined to grow in existing markets, AmorePacific has plans for new market development in the next few years.
These possible markets include Brazil, India, the Middle East and Australia, Park said.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained